Educational Support for Lung Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if education and counseling can improve lung cancer screening rates among individuals with a history of smoking. The researchers propose that better education might help both patients and healthcare providers understand the benefits of early screening, which can detect lung cancer when it's easier to treat. Participants will either engage in educational activities and counseling or complete surveys. Suitable candidates include those who have smoked for at least 20 years, currently smoke or quit within the last 15 years, and haven't had a lung screening in the past 11 months. As an unphased trial, this study offers a unique opportunity to contribute to valuable research that could enhance lung cancer prevention strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on education and counseling for lung cancer screening.
What prior data suggests that this educational intervention is safe for lung cancer screening?
Research has shown that both counseling and education are safe and well-accepted methods to support lung cancer screening. Counseling effectively helps people quit smoking, especially when combined with other treatments, making it both safe and beneficial for those undergoing lung cancer screenings.
Educational programs have increased lung cancer screening rates and improved understanding among patients and healthcare providers. No reports of negative effects from these educational activities indicate they are safe to participate in.
Overall, both counseling and education are non-invasive and carry minimal risk, making them safe choices for anyone considering joining this type of trial.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to improve lung cancer screening through educational support. Unlike traditional treatments that focus directly on medical interventions, this trial emphasizes counseling and education for both patients and healthcare providers. By integrating educational activities and shared decision-making (SDM) counseling, this approach aims to enhance understanding and participation in lung cancer screening. Researchers hope to find out if this method can lead to earlier detection and better outcomes for patients by empowering them and their providers with more information and support.
What evidence suggests that education and counseling might be effective for improving lung cancer screening?
Research has shown that education and counseling can greatly increase lung cancer screening rates. In this trial, Group A (Patients) will participate in educational activities and counseling, which studies have shown lead to more screenings among high-risk individuals. One study discovered that using decision-making tools with doctors increased screening rates, and this strategy will be included in the trial's counseling. Counseling plays a crucial role by helping patients understand the benefits and risks of lung cancer screening, making participation more likely. Overall, these strategies have successfully promoted early detection through screening.16789
Are You a Good Fit for This Trial?
This trial is for adults aged 50-77 who currently smoke or quit within the last 15 years, with a significant smoking history. They must be able to communicate in English or Spanish and have an upcoming primary care visit. Excluded are those recently hospitalized, with dementia, prior lung cancer, or recent CT scans.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Providers and patients undergo educational activities and counseling to improve lung cancer screening
Follow-up
Participants are monitored for repeat annual lung cancer screenings and diagnostic follow-up
Long-term Follow-up
Participants are monitored for tobacco cessation services and lung cancer screening referrals
What Are the Treatments Tested in This Trial?
Interventions
- Counseling
- Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ronald Myers
Lead Sponsor
Thomas Jefferson University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator